Exact Sciences
EXAS
#1165
Rank
A$27.78 B
Marketcap
A$145.54
Share price
0.00%
Change (1 day)
98.92%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -A$0.29 Billion

According to Exact Sciences's latest financial reports the company's current earnings are A$3.24 Billion. , an increase over its 2024 earnings that were of -A$1.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.26 Billion-82.05%
2024 -A$1.41 Billion435.05%
2023 -A$0.27 Billion-69.18%
2022 -A$0.86 Billion-25.77%
2021 -A$1.16 Billion1.68%
2020 -A$1.14 Billion271.17%
2019 -A$0.31 Billion58.99%
2018 -A$0.2 Billion20.89%
2017 -A$0.16 Billion-30.95%
2016 -A$0.23 Billion5.09%
2015 -A$0.22 Billion57.24%
2014 -A$0.14 Billion116.53%
2013 -A$64.23 Million
2011 -A$39.99 Million143.73%
2010 -A$16.41 Million27.85%
2009 -A$12.84 Million0.27%
2008 -A$12.8 Million-20.95%
2007 -A$16.19 Million-13.53%
2006 -A$18.73 Million-10.07%
2005 -A$20.83 Million-21.81%
2004 -A$26.63 Million-33.44%
2003 -A$40.01 Million-6.51%
2002 -A$42.8 Million17.95%
2001 -A$36.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$10.68 B-4,325.25%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$85.92 M-133.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$91.39 M-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-A$0.59 Billion 129.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$48.51 Million-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA